Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-09-07 | 2025-09-07 |
| Drug Identification Number | 00437999 | 00437999 |
| Brand name | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP |
| Common or Proper name | test | test |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE |
| Strength(s) | 150MG 450MG 5G | 150MG 450MG 5G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1234 | 1234 |
| Additional packaging sizes | ||
| ATC code | B05BB | B05BB |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2021-03-02 | 2021-03-02 |
| Actual start date | ||
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | test company comments | test company comments |
| Health Canada comments | test HC comments | test HC comments |